Pharmaceutical companies in Europe play a central role in the global healthcare ecosystem, spanning innovative drug discovery, large-scale pharmaceutical manufacturing, and biologics production.
From multinational pharmaceutical manufacturers headquartered in Switzerland, Germany, and the UK to specialized drug companies across France, Denmark, and Italy, Europe is home to some of the world’s most established and advanced pharmaceutical companies.
The European pharmaceutical industry is characterized by a strong concentration of multinational pharmaceutical companies, advanced regulatory systems, and highly integrated manufacturing networks.
European pharmaceutical companies operate across the full value chain, from drug research and clinical development to commercial-scale pharmaceutical manufacturing. Countries such as Switzerland, Germany, the UK, France, and Denmark are recognized as core hubs for both innovative and manufacturing-focused drug companies.
When researching pharmaceutical companies in Europe, understanding their manufacturing capabilities is essential.
Beyond company size and revenue, the quality, integration, and performance of production equipment play a critical role in ensuring consistent, compliant pharmaceutical manufacturing.
This guide is designed to help readers benchmark leading pharmaceutical manufacturers in Europe and gain insight into the region’s pharmaceutical production landscape.
When building or upgrading a pharmaceutical facility, GMP-compliant and cost-effective manufacturing infrastructure plays a critical role in long-term operational success.
Europe is home to some of the world’s most advanced pharmaceutical companies, accounting for nearly 30% of global drug production. From cutting-edge oncology therapies to biologics and high-containment manufacturing facilities, these industry leaders continue to drive medical innovation and healthcare advancement.
Below are the top pharmaceutical companies in Europe, ranked by their latest publicly reported revenue.
| Rank | Company | Website |
| 1 | Roche | https://www.roche.com/ |
| 2 | Novartis | https://www.novartis.com/ |
| 3 | AstraZeneca | https://www.astrazeneca.com/ |
| 4 | Sanofi | https://www.sanofi.com/en |
| 5 | GSK | https://www.gsk.com/ |
| 6 | Novo Nordisk | https://www.novonordisk.com/ |
| 7 | Bayer | https://www.bayer.com/en/ |
| 8 | Takeda | https://www.takeda.com/ |
| 9 | Ipsen | https://www.ipsen.com/ |
| 10 | Hikma | https://www.hikma.com/ |
Year Founded/Established: 1896
Revenue: $48.7B (-2% YoY)
Manufacturing Focus:
Roche is one of the largest pharmaceutical companies in Europe and a global leader in oncology and diagnostics.
Roche dominates the oncology sector with drugs like Phesgo and Vabysmo, leading innovations in diagnostics and cancer treatments.
The company reinvests over 20% of its revenue in R&D, focusing on high-containment drug production for cytotoxic therapies.
Year Founded/Established: 1996
Revenue: $45.4B (+8% YoY)
Manufacturing Focus:
Novartis specializes in innovative medicines across cardiovascular, immunology, and oncology therapy areas.
Novartis is transitioning into a “pure-play” innovative medicines company following the Sandoz spin-off.
It specializes in cardiovascular, immunology, and oncology treatments, with blockbuster drugs like Eliquis and Opdivo driving growth.
Year Founded/Established: 1913
Revenue: $45.8B (+3% YoY)
Manufacturing Focus:
AstraZeneca leads in oncology, particularly lung cancer therapies such as Tagrisso.
The company is expanding its high-containment drug production for highly potent active pharmaceutical ingredients (HPAPI), supporting its growing biologics pipeline.
Year Founded/Established: 1973
Revenue: $46.2B (+2% YoY)
Manufacturing Focus:
Sanofi is one of the leading pharmaceutical companies in Europe, with a strong focus on vaccines, rare diseases, immunology, and chronic disease treatments.
Sanofi’s growth is powered by its blockbuster immunology drug Dupixent and the RSV vaccine Beyfortus.
The company is also embracing AI-driven drug discovery through its partnership with Aqemia while spinning off its consumer healthcare division.
Year Founded/Established: 1715
Revenue: $37.8B (+3.4% YoY)
Manufacturing Focus:
GSK emphasizes respiratory medicine, vaccines, and infectious disease therapies while advancing immunotherapy and oncology research programs.
GSK is one of the leading pharmaceutical companies in Europe, with a strong focus on vaccines, infectious diseases, respiratory medicine, and immunology.
GSK’s core strength lies in vaccines (Shingrix), respiratory treatments, and HIV therapies. It is investing heavily in oncology, collaborating with Merck KGaA to advance immunotherapy research.
Year Founded/Established: 1923
Revenue: $33.3B (+31.5% YoY)
Manufacturing Focus:
Novo Nordisk leads in diabetes and obesity management, scaling high-containment peptide production and injectable drug manufacturing globally.
Novo Nordisk dominates the obesity and diabetes drug market with Ozempic and Wegovy.
The company is expanding its high-containment capacity to scale up GLP-1 production, ensuring supply meets rising global demand.
Year Founded/Established: 1863
Reputation: Leading pharma brand in China, US, and UK
Manufacturing Focus:
Bayer is one of the leading pharmaceutical companies in Europe, with a strong focus on cardiovascular care, oncology, and specialty pharmaceuticals.
Bayer focuses on cardiovascular, oncology, and women’s health while integrating sustainable practices into API manufacturing.
The company is a pioneer in green chemistry, aligning with global sustainability goals.
Year Founded/Established: 1781
Revenue: $30.3B (+3.5% YoY)
Manufacturing Focus:
Takeda’s European manufacturing centers focus on rare disease medicines, oncology biologics, and high-containment drug production, ensuring compliance with global GMP standards.
Takeda operates major European R&D hubs in Cambridge (UK) and Zurich, driving innovation in rare diseases and oncology.
The company is expanding its biologics pipeline with a focus on high-containment drug manufacturing.
Year Founded/Established: 1929
Specialization: Neurotoxins (Dysport) and oncology (Cabometyx)
Manufacturing Focus:
Ipsen specializes in neurotoxins, oncology drugs, and precision biologics, using AI-driven processes to accelerate drug discovery and manufacturing.
Ipsen is at the forefront of AI-driven drug discovery, partnering with Exscientia to accelerate the development of new cancer therapies.
Year Founded/Established: 1978
Niche: Generics and sterile injectables for high-containment markets
Manufacturing Focus:
Hikma develops generics and sterile injectables for complex markets, with a focus on oncology and high-containment pharmaceutical production.
Hikma is strengthening its position in the European and MENA oncology sectors, investing in specialized drug production for cytotoxic and highly potent compounds.
Pharmaceutical companies such as Roche, Novartis, AstraZeneca, and Sanofi are often described as manufacturers because they operate large production facilities. However, they are not contract manufacturing organizations (CMOs) and do not provide third-party manufacturing services.
Instead, these Big Pharma companies represent the technology direction, manufacturing standards, and investment trends of the European pharmaceutical industry. Their facilities set benchmarks for GMP compliance, high-containment production, automation, and process integration.
While production is done in-house, their manufacturing capabilities rely on advanced pharmaceutical equipment and integrated process solutions.
Their production lines are often powered by specialized equipment suppliers, enabling safe, scalable, and compliant drug manufacturing worldwide.
While this article focuses on pharmaceutical companies in Europe, Canaan Technology is not a pharmaceutical manufacturer and does not produce medicines.
We are a world-renowned manufacturer of pharmaceutical equipment, including automatic capsule filling machines, automatic tablet press machines, pharmaceutical granulation lines, and pharmaceutical turnkey EPC solutions.
While we are not a European contract manufacturer (CMO), our products and services are the engine behind many advanced pharmaceutical facilities globally. Many global leaders utilize our technology across their production sites.
Switzerland and the UK lead in oncology and high-containment drug innovation, while France and Denmark excel in biologics and AI-driven drug discovery.
As the demand for precision medicine and mRNA-based treatments grows, European pharma manufacturers remain at the forefront of global healthcare advancements.
For companies seeking high-containment solutions, partnering with innovative manufacturers like China canaan offers access to advanced pharmaceutical production technologies.
Resources:
Pharmaceutical Company Directory
Top 10 Pharmaceutical Companies in Europe in 2022
Quick Answer Continuous manufacturing pharmaceutical systems merge blending, granulation, and compression into one unbroken line to meet GMP compliance under 21 CFR Part 11. These lines run in-line, real-time quality monitoring instead of end-of-batch testing, typically handling 5 to 40 kg per hour. Canaan’s integrated pharmaceutical continuous manufacturing lines are built to meet these standards, […]
Quick Answer Cleaning validation in pharmaceutical manufacturing is the documented proof that equipment meets a set residue limit every time. A validated wash runs pre-rinse, detergent wash, rinse, and dry stages under fixed time, temperature, and pressure parameters. Canaan’s QD Series washing stations combine automated washing and drying in one controlled cycle, with key process […]
Quick Answer A CIP system cleans fixed pharmaceutical equipment, such as coating machines and fluid-bed dryers, by circulating water and cleaning solution through the system without disassembly. Programmed pressure, temperature, and cycle times help keep each cleaning run consistent. Canaan uses built-in CIP for fixed equipment and QD Series washing stations for bins and IBCs. […]
+86-577-67378828
canaan@chinacanaan.com
